Real-time fMRI Neurofeedback for Mild/Moderate Depression

Depression Mild Clinical Trial

Official title: The Functional Mechanism of the Neurovascular Coupling: an fMRI-EEG Study in Depressive Depression

Status Completed

Clinical Trial Summary

The aim of the study is to compare the effects of the self-regulation (neurofeedback) of the fMRI signal of the prefrontal cortex in depression to ones of more conventional non-pharmacological treatment, primarily, psychotherapy.

Clinical Trial Description

The study was devoted to the neural, clinical, and psychological effects of the rt-fMRI neurofeedback for mild/moderate depression. Recruited unmedicated patients suffering from depression were assigned either to the fMRI neurofeedback (8 sessions of the left prefrontal cortex activity regulation) or to the active control group, i.e., a double dosage of cognitive-behavioral treatment or EEG neurofeedback (preliminary aborted). Depression symptoms were measured at baseline, at mid-treatment, and at post-treatment points. Some inventories of depression and related traits were also given. In the rt-fMRI group, self-regulation learning was also estimated by means of the fMRI signal change. ;

Related Conditions & MeSH terms

• Depression
• Depression Mild
• Depression Moderate
• Depressive Disorder

• NCT number: NCT05025904
• Study type: Interventional
• Source: Federal Research Center of Fundamental and Translational Medicine, Russian Federation
• Status: Completed
• Phase: N/A
• Start date: June 6, 2017
• Completion date: April 9, 2019